Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma

• Emma C. Scott,
• Richard T. Maziarz,
• Stephen E. Spurgeon,
• Eva Medvedova,
• James Gajewski,
• Shara Reasor-Heard,
• Byung Park,
• Anne Kratz,
• George V. Thomas,
• Marc Loriaux,
• Michael Cascio,
• Jennifer Podolak,
• Miranda Gordon,
• Jennifer Botelho,
• Edward Stadtmauer,
• Ravi Amaravadi,
• Dan T. Vogl

Affiliations

Emma C. Scott

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Richard T. Maziarz

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Stephen E. Spurgeon

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Eva Medvedova

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

James Gajewski

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Shara Reasor-Heard

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Byung Park

Public Health and Preventative Medicine, Oregon Health & Science University, the University of Pennsylvania, PN, USA

Anne Kratz

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

George V. Thomas

The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Marc Loriaux

The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Michael Cascio

The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Jennifer Podolak

The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Miranda Gordon

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Jennifer Botelho

The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA

Edward Stadtmauer

Department of Medicine and the Abramson Cancer Center, the University of Pennsylvania, PN, USA

Ravi Amaravadi

Department of Medicine and the Abramson Cancer Center, the University of Pennsylvania, PN, USA

Dan T. Vogl

Department of Medicine and the Abramson Cancer Center, the University of Pennsylvania, PN, USA